A detailed history of Northern Trust Corp transactions in Organovo Holdings, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 24,806 shares of ONVO stock, worth $8,434. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,806
Previous 24,806 -0.0%
Holding current value
$8,434
Previous $18,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.75 - $1.35 $7,600 - $13,680
10,134 Added 69.07%
24,806 $18,000
Q1 2023

May 15, 2023

SELL
$1.44 - $3.2 $21 - $48
-15 Reduced 0.1%
14,672 $32,000
Q4 2022

Feb 13, 2023

BUY
$1.41 - $2.17 $21 - $32
15 Added 0.1%
14,687 $20,000
Q1 2021

May 12, 2021

SELL
$8.67 - $21.7 $5,808 - $14,539
-670 Reduced 4.37%
14,672 $141,000
Q4 2020

Feb 11, 2021

BUY
$7.19 - $17.05 $5,277 - $12,514
734 Added 5.02%
15,342 $189,000
Q3 2020

Nov 16, 2020

BUY
$6.27 - $15.8 $91,592 - $230,806
14,608 New
14,608 $115,000

Others Institutions Holding ONVO

About ORGANOVO HOLDINGS, INC.


  • Ticker ONVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,712,020
  • Market Cap $2.96M
  • Description
  • Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...
More about ONVO
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.